Omega-3 polyunsaturated fatty acids mitigate blood-brain barrier disruption after hypoxic-ischemic brain injury

Neurobiology of Disease

Volumn 91, Issue , 2016, Pages 37-46

  Zhang, Wenting ^a,c   Zhang, Hui ^a,b   Mu, Hongfeng ^a   Zhu, Wen ^c   Jiang, Xiaoyan ^a,c   Hu, Xiaoming ^a,c   Shi, Yejie ^c   Leak, Rehana K ^d   Dong, Qiang ^a,b   Chen, Jun ^a,c,e   Gao, Yanqin ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d DUQUESNE UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Hypoxia ischemia; MMP 2; MMP 9; Tight junction

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE; OMEGA 3 FATTY ACID; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; BRAIN; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; RATS, SPRAGUE-DAWLEY;

EID: 84960899333     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.02.020     Document Type: Article

References (42)

1. Bednarek N., et al. Increased MMP-9 and TIMP-1 in mouse neonatal brain and plasma and in human neonatal plasma after hypoxia-ischemia: a potential marker of neonatal encephalopathy. Pediatr. Res. 2012, 71:63-70.
2. Chang C.Y., et al. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. J. Nutr. Biochem. 2013, 24:2127-2137.
3. Chen W., et al. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J. Neurochem. 2009, 111:726-736.
4. Chen S., et al. n-3 PUFA supplementation benefits microglial responses to myelin pathology. Sci. Rep. 2014, 4:7458.
5. Coisne C., Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid. Redox. Signal. 2011, 15:1285-1303.
6. Deane R., et al. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. J. Neurosci. 2005, 25:11495-11503.
7. Ek C.J., et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J. Cereb. Blood Flow Metab. 2015, 35:818-827.
8. Fernandez-Lopez D., et al. Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. J Neurosci. 2012, 32:9588-9600.
9. Gidday J.M., et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart. Circ. Physiol. 2005, 289:H558-H568.
10. Hahn-Dantona E., et al. The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J Biol Chem. 2001, 276:15498-15503.
11. Hong S.H., et al. Docosahexaenoic acid confers enduring neuroprotection in experimental stroke. J. Neurol. Sci. 2014, 338:135-141.
12. Hong S.H., et al. Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats. Exp. Transl. Stroke. Med. 2015, 7:3.
13. Jeffery R.W., et al. Home testing of urine chloride to estimate dietary sodium intake: evaluation of feasibility and accuracy. Addict. Behav. 1987, 12:17-21.
14. Jin R., et al. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
15. Krueger M., et al. Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2015, 35:292-303.
16. Labus J., et al. Interleukin-1beta induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model. J. Neurosci. Methods 2014, 228:35-45.
17. Li P., et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Ann. Neurol. 2013, 74:458-471.
18. Li P., et al. Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia. Stroke 2013, 44:3509-3515.
19. Liuzzi G.M., et al. Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells - implications for complementary multiple sclerosis treatment. Neurochem. Res. 2007, 32:2184-2193.
20. Maddahi A., et al. Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci. 2009, 10:56.
21. McColl B.W., et al. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 2008, 28:9451-9462.
22. Moretti R., et al. Blood-brain barrier dysfunction in disorders of the developing brain. Front. Neurosci. 2015, 9:40.
23. Muramatsu K., et al. Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier. Stroke 1997, 28:2281-2288. discussion 2288-9.
24. Neuhaus W., et al. The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front. Cell. Neurosci. 2014, 8:352.
25. Petroni A., et al. Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells. Neurochem. Res. 1994, 19:1187-1193.
26. Proulx D.P., et al. Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier?. J. Neuroimmunol. 2012, 251:39-44.
27. Revuelta-Lopez E., et al. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2877-2887.
28. Rozanov D.V., et al. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J Biol Chem. 2004, 279:4260-4268.
29. Shinto L., et al. Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids. 2009, 80:131-136.
30. Shinto L., et al. The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis. Autoimmune Dis. 2011, 2011:134592.
31. Song H., et al. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res. 2009, 69:879-886.
32. Srinivasakumar P., et al. Therapeutic hypothermia in neonatal hypoxic ischemic encephalopathy: electrographic seizures and magnetic resonance imaging evidence of injury. J. Pediatr. 2013, 163:465-470.
33. St-Pierre Y., et al. Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies. Curr. Drug Targets Inflamm. Allergy. 2003, 2:206-215.
34. Svedin P., et al. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J. Neurosci. 2007, 27:1511-1518.
35. Wang J., et al. Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke. Neurobiol. Dis. 2014, 68:91-103.
36. Yang Y., Rosenberg G.A. Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. 2015.
37. Yang Y., et al. Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. J. Cereb. Blood Flow Metab. 2013, 33:1104-1114.
38. Zhang Y., Pardridge W.M. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J. Neuroimmunol. 2001, 114:168-172.
39. Zhang W., et al. Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke 2010, 41:2341-2347.
40. Zhang M., et al. Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1. J. Neurosci. 2014, 34:1903-1915.
41. Zhang W., et al. Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke. Exp. Neurol. 2015, 272:170-180.
42. Zhao Y., Chen L.H. Eicosapentaenoic acid prevents lipopolysaccharide-stimulated DNA binding of activator protein-1 and c-Jun N-terminal kinase activity. J. Nutr. Biochem. 2005, 16:78-84.